The Association of COPD Exacerbations with New Onset Type 2 Diabetes among Medicare Patients

by Joseph S. Marino, Cynthiya Ruban, Christopher M. Blanchette

Probabilistic data linkage: a case study of comparative effectiveness in COPD

by Christopher M Blanchette, Mitch DeKoven, Ajita P De, Melissa Roberts
Published 2013-10-01

Evaluating cost benefits of combination therapies for advanced melanoma

by Ivar S Jensen, Emily Zacherle, Christopher M Blanchette, Jie Zhang, Wes Yin
Published 2016-07-01

Economic burden of chronic bronchitis in the United States: a retrospective case-control study

by Christopher M Blanchette, Melissa H Roberts, Hans Petersen, et al 
Published 2011-01-01

Cachexia & debility diagnoses in hospitalized children and adolescents with complex chronic conditions: evidence from the Kids’ Inpatient Database

by Bryce A Van Doren, Debosree Roy, Joshua M Noone, Christopher M Blanchette, Susan T Arthur
Published 2015-02-01

Depression Following Thrombotic Cardiovascular Events in Elderly Medicare Beneficiaries: Risk of Morbidity and Mortality

by Christopher M. Blanchette, Linda Simoni-Wastila, Fadia T. Shaya, Denise Orwig, Jason Noel, Bruce Stuart
Published 2009-01-01

One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA

by Susan T Arthur, Joshua M Noone, Bryce A Van Doren, Debosoree Roy, Christopher M Blanchette
Published 2014-07-01

One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States

by Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy, Reuben Howden

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

by Michele Wilson, Benjamin Gutierrez, Steve J Offord, Christopher M Blanchette, Anna Eramo, Stephanie Earnshaw, Siddhesh A Kamat
Published 2016-03-01

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.

by Christopher M. Blanchette, Joshua M. Noone, Glenda Stone, Emily Zacherle, Ripsi P. Patel, Reuben Howden, Douglas Mapel
Published 2017-09-01

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease

by Christopher M. Blanchette, Şerban R. Iorga, Aylin Altan, Jerry G. Seare, Ying Fan, Sandro Rossetti, Benjamin Gutierrez

Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease

by Christopher M Blanchette, Caihua Liang, Deborah P Lubeck, Britt Newsome, Sandro Rossetti, Xiangmei Gu, Benjamin Gutierrez, Nancy D Lin
Published 2015-04-01

Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function

by Christopher M Blanchette, Anthony P Nunes, Nancy D Lin, Kathleen M Mortimer, Joshua Noone, Krishna Tangirala, Stephen Johnston, Benjamin Gutierrez
Published 2015-02-01